Amylin Attacked By Carl Icahn Over Buyout SecrecyVW Staff
Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) was under attack today from Carl Icahn over the board of that company's refusal to comment on rumors of a rejected takeover offer. Icahn, who holds an almost 9% stake in the company, was irate after an offer of $22 per share may or may not . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.